Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Morphine in Reducing Early NIV Failure in Acute Exacerbation of COPD
NCT04427826Phase 2Recruiting
- Sponsor
- CHU Grenoble Alpes
- Start
- Dec 2020
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of morphine hydrochloride in chronic obstructive pulmonary disease (COPD), sponsored by CHU Grenoble Alpes. Started Dec 2020; status: recruiting.
02
Drugs
morphine hydrochloride
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04427826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04427826.